Evidence map›Paper›PMID 9722631›Full record

ArticleNucleic acids research1998

The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.

J A Brown, E M Rogers, J M Boss

Open access · bronzeAbstract read
In one paragraph

Article in Nucleic acids research, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

J A BrownDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
E M Rogers
J M Boss
Emory University · US

Funding

MHC Class II Transactivator Function and RegulationR01AI034000 · NIAID · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 1993 to 2009
$2.6M
Regulation of the MHC Class II Transactivator CIITAR56AI034000 · NIAID · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 2010 to 2010
$383k
MHC Class II Bare Lymphocyte Syndrome factorsR21AI034000 · NIAID · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 2003 to 2003
$342k
NIAID NIH HHS AI34000
6 · The paper itself

Abstract

The class II transactivator CIITA is required for transcriptional activation of the major histocompatibility complex (MHC) class II genes. Aside from an N-terminal acidic transcriptional activation domain, little is known about how this factor functions. Extensive mutagenesis of CIITA was undertaken to identify structural motifs required for function. The ability of mutants to activate a reporter gene under the control of MHC class II conserved W-X-Y or X-Y regulatory elements was determined. Two mutants displayed differential activity between the two promoters, activating transcription with the W-X-Y but not the X-Y elements. All mutants were tested for their ability to interfere with wild-type CIITA activity. Five CIITA mutant constructions were able to down-regulate wild-type CIITA activity. Three of these mutants contained targeted disruptions of potential functional motifs: the acidic activation domain, a putative GTP-binding motif and two leucine charged domains (LCD motifs). The other two contained mutations in regions that do not have homology to described proteins. The characterization of CIITA mutants that are able to discriminate between promoters with or without the W box strongly suggests that CIITA requires such interactions for function. The identification of LCD motifs required for CIITA function brings to light a previously undefined role of these motifs in CIITA function.

Indexed as

Genes, MHC Class IILeucineNuclear ProteinsPromoter Regions, GeneticAmino Acid SubstitutionBase SequenceB-LymphocytesBurkitt LymphomaCell LineConserved SequenceDNA PrimersHumansMutagenesis, Site-DirectedPolymerase Chain ReactionRecombinant ProteinsRegulatory Sequences, Nucleic AcidDNA PrimersLeucineMHC class II transactivator proteinNuclear ProteinsRecombinant ProteinsTrans-Activators

Identifiers

PMID9722631
PMCPMC147839
OpenAlexW2041510336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.